Велика Британія -
англійська -
MHRA (Medicines & Healthcare Products Regulatory Agency)
prometax 4.6mg24hours transdermal patches
novartis pharmaceuticals uk ltd - rivastigmine - transdermal patch - 4.6mg/24hour
Велика Британія -
англійська -
MHRA (Medicines & Healthcare Products Regulatory Agency)
ionsys 40microgramsdose transdermal system
the medicines company uk ltd - fentanyl - transdermal system - 40microgram/1dose
Велика Британія -
англійська -
MHRA (Medicines & Healthcare Products Regulatory Agency)
victanyl 12micrograms/hour transdermal patches
accord-uk ltd - fentanyl - transdermal patch - 12microgram/1hour
Австралія -
англійська -
Department of Health (Therapeutic Goods Administration)
exelon patch 15 rivastigmine 13.3mg/24 hours transdermal drug delivery system sachet
novartis pharmaceuticals australia pty ltd - rivastigmine, quantity: 27 mg - drug delivery system, transdermal - excipient ingredients: acrylates copolymer; dl-alpha-tocopherol; dimeticone 12500; ethyl acetate; methylated trimethylated silica; acrylic acid; 2-ethylhexyl acrylate; methyl acrylate; glycidyl methacrylate; 2,2'-azobisisobutyronitrile; hexane - exelon / prometax is indicated for the treatment of patients with mild, moderate and severe dementia of the alzheimer's type.
Австралія -
англійська -
Department of Health (Therapeutic Goods Administration)
exelon patch 10 rivastigmine 9.5mg/24 hours transdermal drug delivery system sachet
novartis pharmaceuticals australia pty ltd - rivastigmine, quantity: 18 mg - drug delivery system, transdermal - excipient ingredients: dimeticone 12500; acrylates copolymer; dl-alpha-tocopherol; ethyl acetate; acrylic acid; 2-ethylhexyl acrylate; methyl acrylate; glycidyl methacrylate; 2,2'-azobisisobutyronitrile; hexane; methylated trimethylated silica - exelon / prometax is indicated for the treatment of patients with mild, moderate and severe dementia of the alzheimer's type.
Австралія -
англійська -
Department of Health (Therapeutic Goods Administration)
exelon patch 5 rivastigmine 4.6mg/24 hours transdermal drug delivery system sachet
novartis pharmaceuticals australia pty ltd - rivastigmine, quantity: 9 mg - drug delivery system, transdermal - excipient ingredients: acrylates copolymer; dimeticone 12500; dl-alpha-tocopherol; ethyl acetate; acrylic acid; 2-ethylhexyl acrylate; methyl acrylate; glycidyl methacrylate; 2,2'-azobisisobutyronitrile; hexane; methylated trimethylated silica - exelon / prometax is indicated for the treatment of patients with mild, moderate and severe dementia of the alzheimer's type.
Велика Британія -
англійська -
MHRA (Medicines & Healthcare Products Regulatory Agency)
nitro-dur 0.2mg/hour transdermal patches
organon pharma (uk) ltd - glyceryl trinitrate - transdermal patch - 5mg/24hour
Велика Британія -
англійська -
MHRA (Medicines & Healthcare Products Regulatory Agency)
nitro-dur 0.4mg/hour transdermal patches
organon pharma (uk) ltd - glyceryl trinitrate - transdermal patch - 10mg/24hour
Велика Британія -
англійська -
MHRA (Medicines & Healthcare Products Regulatory Agency)
nitro-dur 0.6mg/hour transdermal patches
organon pharma (uk) ltd - glyceryl trinitrate - transdermal patch - 15mg/24hour
Велика Британія -
англійська -
MHRA (Medicines & Healthcare Products Regulatory Agency)
transtec 35micrograms/hour transdermal patches
grunenthal ltd - buprenorphine - transdermal patch - 35microgram/1hour